Effectiveness and Safety of Anlotinib with or without S-1 in the Treatment of Patients with Advanced Hepatocellular Carcinoma in Chinese Population: A Prospective, Phase 2 Study. (2023). Radiology and Oncology, 57(3), 405-410. https://www.radioloncol.com/index.php/ro/article/view/4122